Trial · NCT00866307
Adverse events537
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 537
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Abdominal infection | Infections and infestations | Induction | 2 | 104 | 2 |
| other | Abdominal infection | Infections and infestations | Group A (High Risk-Average) | 2 | 54 | 2 |
| other | Abdominal infection | Infections and infestations | Group B (High Risk-High) | 0 | 30 | 0 |
| other | Abdominal pain | Gastrointestinal disorders | Induction | 11 | 104 | 12 |
| other | Abdominal pain | Gastrointestinal disorders | Group A (High Risk-Average) | 8 | 54 | 9 |
| other | Abdominal pain | Gastrointestinal disorders | Group B (High Risk-High) | 3 | 30 | 3 |
| other | Abducens nerve disorder | Nervous system disorders | Induction | 1 | 104 | 1 |
| other | Abducens nerve disorder | Nervous system disorders | Group A (High Risk-Average) | 1 | 54 | 1 |
| other | Abducens nerve disorder | Nervous system disorders | Group B (High Risk-High) | 0 | 30 | 0 |
| other | Activated partial thromboplastin time prolonged | Investigations | Induction | 2 | 104 | 3 |
| other | Activated partial thromboplastin time prolonged | Investigations | Group A (High Risk-Average) | 2 | 54 | 3 |
| other | Activated partial thromboplastin time prolonged | Investigations | Group B (High Risk-High) | 0 | 30 | 0 |
| other | Adult respiratory distress syndrome | Respiratory, thoracic and mediastinal disorders | Induction | 1 | 104 | 1 |
| other | Adult respiratory distress syndrome | Respiratory, thoracic and mediastinal disorders | Group A (High Risk-Average) | 0 | 54 | 0 |
| other | Adult respiratory distress syndrome | Respiratory, thoracic and mediastinal disorders | Group B (High Risk-High) | 0 | 30 | 0 |
| other | Agitation | Psychiatric disorders | Induction | 4 | 104 | 4 |
| other | Agitation | Psychiatric disorders | Group A (High Risk-Average) | 2 | 54 | 2 |
| other | Agitation | Psychiatric disorders | Group B (High Risk-High) | 0 | 30 | 0 |
| other | Alanine aminotransferase increased | Investigations | Induction | 47 | 104 | 100 |
| other | Alanine aminotransferase increased | Investigations | Group A (High Risk-Average) | 28 | 54 | 70 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00866307/events